Angina can go away, but whether it does depends on what’s causing it and how it’s treated. Individual episodes of stable angina typically ease within a few minutes of resting or taking nitroglycerin. The underlying condition that produces angina, usually narrowed coronary arteries, is a longer-term problem that requires ongoing management but can improve significantly with the right combination of lifestyle changes and medical treatment.
How Quickly an Episode Resolves
A typical stable angina episode lasts a few minutes. It follows a predictable pattern: physical activity, emotional stress, or cold weather triggers chest pressure, and the pressure fades once you stop and rest. Sublingual nitroglycerin, the small tablet or spray placed under the tongue, begins working within about two minutes by widening blood vessels and restoring blood flow to the heart muscle. Its effect wears off within an hour or so, but by then the episode has passed.
If your chest pain lasts longer than a few minutes and doesn’t respond to rest or nitroglycerin, that’s a different situation. Unstable angina is more severe, can strike without a trigger, and may persist for 20 minutes or longer. Pain that doesn’t let up is a warning that blood flow to part of the heart is critically reduced, and a heart attack may be underway. That kind of chest pain needs emergency care.
Why the Underlying Cause Matters
Angina is a symptom, not a disease in itself. It signals that your heart muscle isn’t getting enough oxygen-rich blood, almost always because fatty deposits have narrowed one or more coronary arteries. So the real question behind “will angina go away” is whether that narrowing can be stopped or reversed.
In many cases, the answer is yes, at least partially. The Lifestyle Heart Trial, published in The Lancet, put 28 patients on an intensive program of a low-fat vegetarian diet, smoking cessation, stress management, and moderate exercise. After one year, 82% of those patients showed measurable reversal of their artery narrowing. The average blockage shrank from 40% to about 38%, while a comparison group that didn’t make those changes saw their blockages worsen from roughly 43% to 46%. Even severely narrowed arteries (over 50% blocked) improved, dropping from about 61% to 56% stenosis in the lifestyle group. These are modest numbers, but they moved in the right direction, and patients reported fewer angina symptoms as a result.
How Medications Reduce Symptoms
Most people with stable angina are prescribed daily medications that reduce how often episodes occur or prevent them altogether. Two main categories of drugs serve as first-line treatment: beta-blockers and calcium channel blockers. Beta-blockers slow the heart rate and reduce the force of each heartbeat, so the heart needs less oxygen during activity. Calcium channel blockers relax and widen blood vessels, improving blood flow to the heart while also lowering blood pressure.
Clinical trials have found both drug classes perform similarly. The TIBET trial showed that a beta-blocker and a calcium channel blocker produced comparable anti-angina benefits, and combining the two didn’t add significant improvement. The APSIS trial confirmed that patients on either type had similar rates of cardiovascular events over time. For beta-blockers, doctors typically aim for a resting heart rate of 50 to 60 beats per minute, adjusting the dose until symptoms are well controlled.
For many patients, this combination of daily medication and lifestyle adjustments reduces angina to rare or nonexistent episodes. You may go weeks or months without chest pain, especially if you manage your activity level and avoid known triggers.
Long-Term Outlook With Treatment
Stable angina that responds to treatment carries a relatively favorable prognosis. A nine-year follow-up of angina patients in the APSIS study found an overall mortality rate of 1.7% per year, with cardiovascular death accounting for about 1% per year. Women with stable angina had mortality rates similar to the general female population. Men had somewhat higher mortality than the general male population during the first three years after diagnosis, but after that initial period, their survival curves ran parallel to men without heart disease.
These numbers reflect patients who were actively treated and monitored. They underscore that angina doesn’t have to define your life expectancy, particularly when you stay on medication and make sustained changes to diet, exercise, and smoking habits.
What Happens After a Stent or Procedure
When medications and lifestyle changes aren’t enough, a procedure to physically open the blocked artery is the next step. Coronary angioplasty with a stent is the most common approach. It works well for many people, but it’s not a guaranteed permanent fix. Data from the NHLBI Dynamic Registry found that 26% of patients still experienced angina episodes 12 months after stent placement. The ARTS trial reported similar numbers: 21% had angina at one year, and by five years, 42% had either recurring angina or needed a repeat procedure.
That doesn’t mean the procedure failed. Many of those patients had less frequent or less severe symptoms than before. But it does mean stents aren’t a cure. The disease process that narrowed your arteries in the first place can affect other segments of the same artery or different arteries entirely. Ongoing medication and lifestyle management remain essential even after a successful procedure.
When Angina Doesn’t Respond to Treatment
A small percentage of patients develop what’s called refractory angina, defined as symptoms persisting for more than three months despite standard medications and procedures. This is a more serious situation. Five-year mortality in patients with refractory angina approaches 20%, mostly from cardiovascular causes.
Newer device-based therapies offer some relief for this group. The most established is a small implant placed in the coronary sinus, a large vein that drains blood from the heart muscle. A 2025 analysis of over 1,500 patients found that 70% experienced meaningful symptom improvement after receiving this device, with a 99% implantation success rate and only a 2% complication rate. Other options include spinal cord stimulation, which uses mild electrical pulses to reduce pain signals, and external counterpulsation, a seven-week course of sessions that uses inflatable cuffs on the legs to boost blood flow back to the heart.
Could It Be Something Other Than Your Heart?
Not all chest pain that feels like angina comes from the heart. Among patients evaluated for chest pain who turn out not to have a cardiac cause, musculoskeletal problems account for 36% to 49% of cases, including inflammation of the cartilage connecting the ribs to the breastbone. Gastrointestinal causes make up another significant portion, with acid reflux responsible for 50% to 60% of non-cardiac chest pain. Anxiety and other psychiatric conditions explain 5% to 11%.
This distinction matters because non-cardiac chest pain often resolves with very different treatment. Reflux-related chest pain typically improves with acid-suppressing medication. Musculoskeletal pain responds to anti-inflammatory treatment and time. If your chest pain doesn’t follow the classic angina pattern of being triggered by exertion and relieved by rest, it’s worth exploring whether something other than your heart is the source. That kind of chest pain genuinely can go away completely once the underlying cause is addressed.